Hepatitis B

Idenix Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of drugs for the treatment of human viral and other infectious diseases. The company developed Tyzeka/Sebivo through a co development agreement with Novartis Pharma AG for the treatment of patients with chronic hepatitis B in the United States and European Union for the treatment of patients with chronic hepatitis B.

GSK employees serve US communities by discovering, developing, and delivering new medicines, vaccines, and other healthcare products to help people do more, feel better, and live longer